Federal Register #2026-16730

Executive Order Directs Update of Childhood Vaccine Recommendations—No Procurement Action

This executive order from the Executive Office of the President outlines a directive for federal agencies to update and align childhood vaccine recommendations: - Government Buyer: - Executive Office of the President - Department of Health and Human Services (HHS) and related agencies - No OEMs or vendors are specified in the order - Products/Services Requested: - No procurement of products or services is requested - The order lists vaccines recommended for all children (measles, mumps, rubella, diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type B, pneumococcal disease, human papillomavirus, varicella) - Vaccines for high-risk groups (respiratory syncytial virus monoclonal antibodies, hepatitis A, hepatitis B, meningococcal B, meningococcal ACWY, dengue) - Vaccines based on shared clinical decision-making (hepatitis A, hepatitis B, rotavirus, meningococcal disease, influenza, COVID-19) - Unique/Notable Requirements: - Emphasis on aligning recommendations with scientific evidence and international best practices - Calls for development of single-disease vaccine options - Focus on improved vaccine safety monitoring and continuous reassessment - Parental choice and transparency highlighted - No procurement action, contract, or solicitation is present in this document

Description

This executive order issued by the President outlines the delivery of gold standard childhood vaccine recommendations for Americans. It emphasizes aligning U.S. childhood vaccine recommendations with best practices from peer developed countries, supporting parental choice, and improving vaccine research and safety. The order directs federal agencies to review and advance these recommendations and advises states to consider updating immunization laws accordingly. It also mandates reassessment of vaccine recommendations based on ongoing scientific findings.

View original listing